The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Infection Control in Cancer Therapy-Global Market Insights and Sales Trends 2025
Synopsis
The global Infection Control in Cancer Therapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Infection Control in Cancer Therapy in various end use industries. The expanding demands from the Hospital, Pharmaceutical Companies, Medical device companies and Other, are propelling Infection Control in Cancer Therapy market. Radiation Therapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Immunotherapy segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Infection Control in Cancer Therapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Infection Control in Cancer Therapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Infection Control in Cancer Therapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Infection Control in Cancer Therapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Infection Control in Cancer Therapy covered in this report include Kimberly Clark Corporation, 3M Healthcare Company, Honeywell International, Inc., Getinge Group AB, Sterigenics International, Sakura Global Holding Company, Arizant Healthcare Inc., Nordion and Cisa S.P.A., etc.
The global Infection Control in Cancer Therapy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Kimberly Clark Corporation
3M Healthcare Company
Honeywell International, Inc.
Getinge Group AB
Sterigenics International
Sakura Global Holding Company
Arizant Healthcare Inc.
Nordion
Cisa S.P.A.
Steris Corporation
Nordion, Inc.
Ahlstrom Filtration LLC
Membrana GmbH
Synergy Health, Plc
Advanced Sterilization Products Services, Inc
Global Infection Control in Cancer Therapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Infection Control in Cancer Therapy market, Segment by Type:
Radiation Therapy
Immunotherapy
Traditional Surgery
Stem Cell Transplant Therapy
Chemotherapy
Targeted Therapy
Photodynamic Therapy
Other
Global Infection Control in Cancer Therapy market, by Application
Hospital
Pharmaceutical Companies
Medical device companies
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Infection Control in Cancer Therapy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Infection Control in Cancer Therapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Infection Control in Cancer Therapy in various end use industries. The expanding demands from the Hospital, Pharmaceutical Companies, Medical device companies and Other, are propelling Infection Control in Cancer Therapy market. Radiation Therapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Immunotherapy segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Infection Control in Cancer Therapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Infection Control in Cancer Therapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Infection Control in Cancer Therapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Infection Control in Cancer Therapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Infection Control in Cancer Therapy covered in this report include Kimberly Clark Corporation, 3M Healthcare Company, Honeywell International, Inc., Getinge Group AB, Sterigenics International, Sakura Global Holding Company, Arizant Healthcare Inc., Nordion and Cisa S.P.A., etc.
The global Infection Control in Cancer Therapy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Kimberly Clark Corporation
3M Healthcare Company
Honeywell International, Inc.
Getinge Group AB
Sterigenics International
Sakura Global Holding Company
Arizant Healthcare Inc.
Nordion
Cisa S.P.A.
Steris Corporation
Nordion, Inc.
Ahlstrom Filtration LLC
Membrana GmbH
Synergy Health, Plc
Advanced Sterilization Products Services, Inc
Global Infection Control in Cancer Therapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Infection Control in Cancer Therapy market, Segment by Type:
Radiation Therapy
Immunotherapy
Traditional Surgery
Stem Cell Transplant Therapy
Chemotherapy
Targeted Therapy
Photodynamic Therapy
Other
Global Infection Control in Cancer Therapy market, by Application
Hospital
Pharmaceutical Companies
Medical device companies
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Infection Control in Cancer Therapy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Infection Control in Cancer Therapy
1.1 Infection Control in Cancer Therapy Market Overview
1.1.1 Infection Control in Cancer Therapy Product Scope
1.1.2 Infection Control in Cancer Therapy Market Status and Outlook
1.2 Global Infection Control in Cancer Therapy Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Infection Control in Cancer Therapy Market Size by Region (2018-2029)
1.4 Global Infection Control in Cancer Therapy Historic Market Size by Region (2018-2023)
1.5 Global Infection Control in Cancer Therapy Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Infection Control in Cancer Therapy Market Size (2018-2029)
1.6.1 North America Infection Control in Cancer Therapy Market Size (2018-2029)
1.6.2 Europe Infection Control in Cancer Therapy Market Size (2018-2029)
1.6.3 Asia-Pacific Infection Control in Cancer Therapy Market Size (2018-2029)
1.6.4 Latin America Infection Control in Cancer Therapy Market Size (2018-2029)
1.6.5 Middle East & Africa Infection Control in Cancer Therapy Market Size (2018-2029)
2 Infection Control in Cancer Therapy Market by Type
2.1 Introduction
2.1.1 Radiation Therapy
2.1.2 Immunotherapy
2.1.3 Traditional Surgery
2.1.4 Stem Cell Transplant Therapy
2.1.5 Chemotherapy
2.1.6 Targeted Therapy
2.1.7 Photodynamic Therapy
2.1.8 Other
2.2 Global Infection Control in Cancer Therapy Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Infection Control in Cancer Therapy Historic Market Size by Type (2018-2023)
2.2.2 Global Infection Control in Cancer Therapy Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Infection Control in Cancer Therapy Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Infection Control in Cancer Therapy Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Infection Control in Cancer Therapy Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Infection Control in Cancer Therapy Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Infection Control in Cancer Therapy Revenue Breakdown by Type (2018-2029)
3 Infection Control in Cancer Therapy Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Pharmaceutical Companies
3.1.3 Medical device companies
3.1.4 Other
3.2 Global Infection Control in Cancer Therapy Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Infection Control in Cancer Therapy Historic Market Size by Application (2018-2023)
3.2.2 Global Infection Control in Cancer Therapy Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Infection Control in Cancer Therapy Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Infection Control in Cancer Therapy Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Infection Control in Cancer Therapy Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Infection Control in Cancer Therapy Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Infection Control in Cancer Therapy Revenue Breakdown by Application (2018-2029)
4 Infection Control in Cancer Therapy Competition Analysis by Players
4.1 Global Infection Control in Cancer Therapy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Infection Control in Cancer Therapy as of 2022)
4.3 Date of Key Players Enter into Infection Control in Cancer Therapy Market
4.4 Global Top Players Infection Control in Cancer Therapy Headquarters and Area Served
4.5 Key Players Infection Control in Cancer Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 Infection Control in Cancer Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Kimberly Clark Corporation
5.1.1 Kimberly Clark Corporation Profile
5.1.2 Kimberly Clark Corporation Main Business
5.1.3 Kimberly Clark Corporation Infection Control in Cancer Therapy Products, Services and Solutions
5.1.4 Kimberly Clark Corporation Infection Control in Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.1.5 Kimberly Clark Corporation Recent Developments
5.2 3M Healthcare Company
5.2.1 3M Healthcare Company Profile
5.2.2 3M Healthcare Company Main Business
5.2.3 3M Healthcare Company Infection Control in Cancer Therapy Products, Services and Solutions
5.2.4 3M Healthcare Company Infection Control in Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.2.5 3M Healthcare Company Recent Developments
5.3 Honeywell International, Inc.
5.3.1 Honeywell International, Inc. Profile
5.3.2 Honeywell International, Inc. Main Business
5.3.3 Honeywell International, Inc. Infection Control in Cancer Therapy Products, Services and Solutions
5.3.4 Honeywell International, Inc. Infection Control in Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.3.5 Getinge Group AB Recent Developments
5.4 Getinge Group AB
5.4.1 Getinge Group AB Profile
5.4.2 Getinge Group AB Main Business
5.4.3 Getinge Group AB Infection Control in Cancer Therapy Products, Services and Solutions
5.4.4 Getinge Group AB Infection Control in Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.4.5 Getinge Group AB Recent Developments
5.5 Sterigenics International
5.5.1 Sterigenics International Profile
5.5.2 Sterigenics International Main Business
5.5.3 Sterigenics International Infection Control in Cancer Therapy Products, Services and Solutions
5.5.4 Sterigenics International Infection Control in Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.5.5 Sterigenics International Recent Developments
5.6 Sakura Global Holding Company
5.6.1 Sakura Global Holding Company Profile
5.6.2 Sakura Global Holding Company Main Business
5.6.3 Sakura Global Holding Company Infection Control in Cancer Therapy Products, Services and Solutions
5.6.4 Sakura Global Holding Company Infection Control in Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.6.5 Sakura Global Holding Company Recent Developments
5.7 Arizant Healthcare Inc.
5.7.1 Arizant Healthcare Inc. Profile
5.7.2 Arizant Healthcare Inc. Main Business
5.7.3 Arizant Healthcare Inc. Infection Control in Cancer Therapy Products, Services and Solutions
5.7.4 Arizant Healthcare Inc. Infection Control in Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.7.5 Arizant Healthcare Inc. Recent Developments
5.8 Nordion
5.8.1 Nordion Profile
5.8.2 Nordion Main Business
5.8.3 Nordion Infection Control in Cancer Therapy Products, Services and Solutions
5.8.4 Nordion Infection Control in Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.8.5 Nordion Recent Developments
5.9 Cisa S.P.A.
5.9.1 Cisa S.P.A. Profile
5.9.2 Cisa S.P.A. Main Business
5.9.3 Cisa S.P.A. Infection Control in Cancer Therapy Products, Services and Solutions
5.9.4 Cisa S.P.A. Infection Control in Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.9.5 Cisa S.P.A. Recent Developments
5.10 Steris Corporation
5.10.1 Steris Corporation Profile
5.10.2 Steris Corporation Main Business
5.10.3 Steris Corporation Infection Control in Cancer Therapy Products, Services and Solutions
5.10.4 Steris Corporation Infection Control in Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.10.5 Steris Corporation Recent Developments
5.11 Nordion, Inc.
5.11.1 Nordion, Inc. Profile
5.11.2 Nordion, Inc. Main Business
5.11.3 Nordion, Inc. Infection Control in Cancer Therapy Products, Services and Solutions
5.11.4 Nordion, Inc. Infection Control in Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.11.5 Nordion, Inc. Recent Developments
5.12 Ahlstrom Filtration LLC
5.12.1 Ahlstrom Filtration LLC Profile
5.12.2 Ahlstrom Filtration LLC Main Business
5.12.3 Ahlstrom Filtration LLC Infection Control in Cancer Therapy Products, Services and Solutions
5.12.4 Ahlstrom Filtration LLC Infection Control in Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.12.5 Ahlstrom Filtration LLC Recent Developments
5.13 Membrana GmbH
5.13.1 Membrana GmbH Profile
5.13.2 Membrana GmbH Main Business
5.13.3 Membrana GmbH Infection Control in Cancer Therapy Products, Services and Solutions
5.13.4 Membrana GmbH Infection Control in Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.13.5 Membrana GmbH Recent Developments
5.14 Synergy Health, Plc
5.14.1 Synergy Health, Plc Profile
5.14.2 Synergy Health, Plc Main Business
5.14.3 Synergy Health, Plc Infection Control in Cancer Therapy Products, Services and Solutions
5.14.4 Synergy Health, Plc Infection Control in Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.14.5 Synergy Health, Plc Recent Developments
5.15 Advanced Sterilization Products Services, Inc
5.15.1 Advanced Sterilization Products Services, Inc Profile
5.15.2 Advanced Sterilization Products Services, Inc Main Business
5.15.3 Advanced Sterilization Products Services, Inc Infection Control in Cancer Therapy Products, Services and Solutions
5.15.4 Advanced Sterilization Products Services, Inc Infection Control in Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.15.5 Advanced Sterilization Products Services, Inc Recent Developments
6 North America
6.1 North America Infection Control in Cancer Therapy Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Infection Control in Cancer Therapy Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Infection Control in Cancer Therapy Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Infection Control in Cancer Therapy Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Infection Control in Cancer Therapy Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Infection Control in Cancer Therapy Market Dynamics
11.1 Infection Control in Cancer Therapy Industry Trends
11.2 Infection Control in Cancer Therapy Market Drivers
11.3 Infection Control in Cancer Therapy Market Challenges
11.4 Infection Control in Cancer Therapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Industrial Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
